valaciclovir hydrochloride Tablets 0.15 g - 2 ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #38955
Established in the 1990s, this Chinese pharmaceutical manufacturer brings three decades of Rx injectable and oral formulation production experience. Portfolio of APIs, intermediates, and finished dosage forms spans oncology, cardiovascular, and metabolic therapy areas. International GMP certifications support export to regulated global markets.
Manufacturer usually replies in 51 days
None